Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / SHS
-
Total 13F shares
-
5,898,340
-
Share change
-
+555,800
-
Total reported value
-
$1,157,779
-
Price per share
-
$0.20
-
Number of holders
-
17
-
Value change
-
-$30,213
-
Number of buys
-
7
-
Number of sells
-
10
Institutional Holders of INTEC PHARMA LTD JERUSALEM - SHS as of Q1 2020
As of 31 Mar 2020,
INTEC PHARMA LTD JERUSALEM - SHS was held by
17 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,898,340 shares.
The largest 10 holders included
MEITAV DASH INVESTMENTS LTD, ADAGE CAPITAL PARTNERS GP, L.L.C., Phoenix Holdings Ltd., AdvisorShares Investments LLC, ETF MANAGERS GROUP, LLC, RENAISSANCE TECHNOLOGIES LLC, CITADEL ADVISORS LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, MORGAN STANLEY, and UBS Group AG.
This page lists
17
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.